SCHEMBL25480

SCHEMBL25480

O=CNCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL27648795 1.00
Hydrochloric Acid SCHEMBL27452098 0.97
Ammonia Solution, Strong SCHEMBL27190158 0.97
Water SCHEMBL1273106 0.97
SCHEMBL28180337 0.97
Benzene SCHEMBL28031841 0.94 ADH1B (0.41)
Glycine SCHEMBL27813806 0.89 GLRA1 (0.50)
SCHEMBL11763542 0.85 ALDH1A1 (0.34)
SCHEMBL11761146 0.85 ALDH1A1 (0.34)
SCHEMBL11761029 0.85 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5083 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075713-A Deaminase and use of transaminase in the treatment of polyglutamine diseases 2026-05-26 CN claimed
US-20260103737-A1 ENZYMATIC METHODS TO GENERATE HIGH YIELDS OF SEQUENCE SPECIFIC RNA OLIGONUCLEOTIDES WITH EXTREME PRECISION UNIV MASSACHUSETTS (US) 2026-04-16 US claimed
US-20260091067-A1 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MARVELBIOME INC (US) 2026-04-02 US claimed
US-20260078178-A1 METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATASE ACTIVITY IN THE CNS ARMAGEN INC (US) 2026-03-19 US claimed
US-20260063641-A1 COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS UNIV UTAH RES FOUND (US) 2026-03-05 US claimed
EP-4698231-A1 CLEAVABLE IMMUNE CELL ENGAGERS Synaffix B.V. (NL) 2026-02-25 EP claimed
EP-4615982-A2 SURFACE-MODIFIED LIPID NANOPARTICLES Tessera Therapeutics, Inc. (US) 2025-09-17 EP claimed
EP-4615417-A2 LIPID NANOPARTICLE DRUG CONJUGATES Tessera Therapeutics, Inc. (US) 2025-09-17 EP claimed
EP-4587116-A2 METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES MarvelBiome, Inc. (US) 2025-07-23 EP claimed
US-20250228907-A1 COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS THE CHILDREN'S HOSPITAL OF PHILADELPHIA 2025-07-17 US claimed
US-4749691-A Peptide, process for preparation thereof and use thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-07 US claimed
US-4727060-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1988-02-23 US claimed
US-4725582-A IMMUNE RESPONSE ENHANCERS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1988-02-16 US claimed
EP-0250013-A1 Technetium chelates to be used for determining the renal function MALLINCKRODT, INC.(a Missouri corporation) (US) 1987-12-23 EP claimed
EP-0025842-B1 PEPTIDES, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-03 EP claimed
EP-0071926-B1 NEW RIBOFURANURONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-08 EP claimed
EP-0098159-B1 PREPARATION OF N-PHOSPHONOMETHYLGLYCINE STAUFFER CHEMICAL COMPANY (US) 1986-09-03 EP claimed
EP-0071926-A1 New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-02-16 EP claimed
US-4180395-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1979-12-25 US claimed
US-3954981-A Triazolocycloalkylhydrothiadiazine derivatives RICHARDSON-MERRELL INC. (US) 1976-05-04 US claimed